Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy
Treatment failure of solid cancers, represented by the development of drug resistance in the primary tumor or later outgrowth of drug resistant metastases, is the major cause of death for cancer patients. It represents an urgent clinical need for predictive biomarkers which indicate the success or f...
Main Authors: | Mathias Dahlmann, Rebecca Werner, Benedikt Kortüm, Dennis Kobelt, Wolfgang Walther, Ulrike Stein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00599/full |
Similar Items
-
MACC1 driven alterations in cellular biomechanics facilitate cell motility in glioblastoma
by: Tim Hohmann, et al.
Published: (2020-06-01) -
Systematic Identification of MACC1-Driven Metabolic Networks in Colorectal Cancer
by: Jan Lisec, et al.
Published: (2021-02-01) -
Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells
by: Nazli Güllü, et al.
Published: (2020-08-01) -
SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer
by: Schmid Felicitas, et al.
Published: (2012-07-01) -
Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1
by: Dennis Kobelt, et al.
Published: (2020-05-01)